Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical data trend for Otsuka Holdings Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4578N vs LLY, JNJ, ABBV: FCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Otsuka Holdings Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otsuka Holdings Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Otsuka Holdings Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Otsuka Holdings Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otsuka Holdings Co (MEX:4578N) has a FCF Margin % of -4.66% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Otsuka Holdings Co and its competitors. Over the past decade, Otsuka Holdings Co's FCF Margin % has ranged from 2.04 to 10.61. According to the industry distribution chart, Otsuka Holdings Co ranks #391 out of 960 companies in the Drug Manufacturers industry, placing it in the top 40.7%.
Is Otsuka Holdings Co's FCF Margin % too high?
Otsuka Holdings Co's current FCF Margin % is -4.66%. Over the past 10 years, this metric has ranged from a low of 2.04 to a high of 10.61. Based on the distribution chart, Otsuka Holdings Co ranks #391 out of 960 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Otsuka Holdings Co has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Otsuka Holdings Co's FCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Otsuka Holdings Co ranks #391 out of 960 companies for FCF Margin %. This puts Otsuka Holdings Co in the upper half of its industry. The industry median FCF Margin % is 2.39. Historically, Otsuka Holdings Co's own FCF Margin % has ranged from 2.04 to 10.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.39, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Otsuka Holdings Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otsuka Holdings Co's current FCF Margin % is -4.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otsuka Holdings Co stock overvalued right now?
Otsuka Holdings Co (MEX:4578N) has a current FCF Margin % of -4.66%. The stock's GF Value™ is MXN749.44, compared to a current price of MXN1,025.98 — trading 36.9% above its estimated fair value. The current FCF Margin % is -4.66%. Otsuka Holdings Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Otsuka Holdings Co (MEX:4578N), the current FCF Margin % is -4.66% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Otsuka Holdings Co (MEX:4578N) Overvalued in 2026?
Based on GuruFocus' analysis, Otsuka Holdings Co stock appears to be overvalued.
The current stock price of MXN1,025.98 is trading 36.9% above its estimated GF Value™ of MXN749.44.
Key valuation signals for MEX:4578N:
FCF Margin %: -4.66%
GF Value™: MXN749.44 vs. price of MXN1,025.98 (36.9% above fair value)
No single metric tells the full story. See the MEX:4578N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Otsuka Holdings Co Ltd is a Japan-based company that operates in pharmaceuticals, nutraceuticals, and consumer products. It operates through four reportable segments: Medical-related Business, Nutraceutical-related Business, Consumer-related Business, and Other Business. The Medical Business manufactures and sells therapeutic drugs and infusions, the Nutraceutical Business produces functional foods, beverages, and nutritional supplements, the Consumer Business offers mineral water, beverages, and foods, while the Other Business provides storage services and manufactures chemicals and analytical equipment. It generates the majority of its revenue from the medical-related business segment.
86GF Score
Get the complete analysis for MEX:4578N
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4578N has been successfully added to your 
